Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026
Key Highlights
- ➤Aytu will report fiscal 2027 first-quarter results November 16 after market close
- ➤Conference call and webcast scheduled for November 16 at 4:30 p.m. Eastern time
- ➤Aytu markets EXXUA and treatments for attention deficit-hyperactivity disorder
Expert Statements
Ryan Selhorn, Chief Financial Officer of Aytu BioPharma, Inc.
“Company contacts listed for investors; no direct statement provided.”
DENVER, CO / ACCESS Newswire / November 10, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its fiscal 2027 first quarter after the market close on Monday, November 16, 2026. The Company has scheduled a conference call and webcast that same day, Monday, November 16, 2026, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.
Date and Time: Monday, November 16, 2026, at 4:30 p.m. Eastern time.
Get started
Create a free account to read the full story.